• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Holdings
© 2025 Longbridge|Disclaimer

Schedules & Filings

Schedules
Filings
Dec19
Distribution Plan(EST)

Cash dividend 0.3198 USD

Dec16
Distribution Plan(EST)

Cash dividend 0.3198 USD

Distribution Plan(EST)

Cash dividend 0.3198 USD

View More

Event Tracking

Dec29
Analyst Raises Praxis Precision Medicines Target Price to $534
16:27
Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation; Pre-Market Stock Up Over 11%
13:35
Praxis Precision Medicines' Drug Ulixacaltamide Receives FDA Breakthrough Therapy Designation
13:16
BTIG analyst reiterates Praxis Precision Medicines stock buy rating
11:21
Dec28
J. L. Bainbridge & Co. Inc. significantly reduced holdings in Biogen Inc. stocks
12:34
Dec26
Deutsche Bank Maintains Neurocrine Biosciences Stock Rating and Price Target
10:41